KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--C3i Healthcare Connections, a division of Telerx and an industry-leading business process outsourcer specializing in the multi-channel engagement of patients, healthcare professionals and enterprise personnel, today announced it has been positioned by Gartner Inc. in the 2015 Magic Quadrant for End-User Outsourcing (EUO) Services, North America. 1 Source: Gartner, Inc., Magic Quadrant for End-User Outsourcing Services, North America, David Edward Ackerman, Daniel Barros, Helen Huntley, 19 August 2015.
Gartner’s Magic Quadrant offers visual snapshots of a market’s direction, maturity and participants and evaluates companies on completeness of vision and ability to execute. According to the Gartner report, “New solutions in the North American EUO service market are fueling client interest in the use of service providers to manage their service desk/help desk, desktop and mobility needs.”
“The life sciences industry is facing unprecedented challenges and opportunities to further improve healthcare outcomes,” said Mike Brannan, Telerx’s chief innovation officer. “From business process expertise to multi-channel engagement solutions, we are committed to delivering a customer-centric approach that gives our clients a unique advantage in this ever-changing healthcare climate to not only improve their process, but also positively impact the outcomes.”
C3i Healthcare Connections has more than 30 years of experience delivering innovative multi-channel solutions to the global life sciences industry across 100 countries, including:
- Commercial Services: Patient support and adherence and sales & marketing support to enhance patient engagement
- Digital Services: Digital health tools, such as remote patient monitoring and social media monitoring and engagement
- Enterprise Services: Information technology for remote and office-based professionals
- Medical Services: End-to-end solution for all product safety, medical information and regulatory compliance needs
For more information about C3i Healthcare Connections and its global, multi-channel engagement solutions, visit C3iHC.com.
About the Magic Quadrant
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
About C3i Healthcare Connections
C3i Healthcare Connections, a division of Telerx, is an industry-leading business process outsourcer specializing in the multi-channel engagement of patients, healthcare professionals and enterprise personnel via a network of global contact centers. For more information, visit C3iHC.com or connect via Facebook, Twitter, LinkedIn and Google+.
Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook and YouTube.
Forward-Looking Statement of Merck & Co. Inc., Kenilworth, NJ, USA
This news release of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2014 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).